COVID-19 is an unusual and unpredictable virus throughout structure, contagiousness, and pathogenic. The virus may lead to severe pneumonia, acute respiratory distress syndrome, sepsis, multiple organ failure, acute kidney, and heart damage. Nevertheless, Russian doctors have learned successfully to fight this disease.
In April 2020, in St. Petersburg studies were conducted using a moderate to severe course of COVID infection. The use of thymus peptides in the complex therapy restores and boosts the immune system, increases the number of T-lymphocytes and decreases C-reactive protein by 5-6 times. Also it reduces the indicator of dangerous thrombus formation by approximately 5 times that does not allow the transition of the disease to more severe stages. Thus, bio-regulators based on thymus peptides may become an effective addition to basic therapy. They help to eliminate immune system defects and elaborate adequate immune response.
One of the most efficient ways to support your body is with PEPTIDE COMPLEXES.
The crucial components are thymus regulatory peptides for the immune system – CRYSTAGEN®, VLADONIX®, PROTECTOR 3 Plus® and regulatory peptides for the lungs and bronchi – CHONLUTEN®, BRONCHOGEN®, TAXOREST®.